Pregabalin (Lyrica)

Pregabalin (Lyrica) is an anti-seizure drug that can be used to prevent fits, as well as in the treatment of pain caused by nerve damage (neuropathy). It can also reduce anxiety levels. It is manufactured by Pfizer.

Pregabalin is approved for the treatment of epilepsy and the pain caused by neuropathy due to diabetes and herpes. However, its use in treating the pain due to neuropathy caused by HIV or HIV treatment is experimental.

Pregabalin’s major side-effects include dizziness and drowsiness. It is not known to interact with any other medications, although test-tube studies suggest that it may increase the drowsiness caused by alcohol.

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.